Nakamura K, Lazari M F, Li S, Korgaonkar C, Ascoli M
Department of Pharmacology, The University of Iowa College of Medicine, Iowa City 52242-1109, USA.
Mol Endocrinol. 1999 Aug;13(8):1295-304. doi: 10.1210/mend.13.8.0331.
The extent of agonist-induced down-regulation of the LH/CG receptor (LHR) in human kidney 293 cells transfected with the rat LHR (rLHR) is much lower than in two Leydig tumor cell lines (MA-10 and R2C) that express the rodent LHR endogenously. This difference can not be attributed to differences in the recycling of internalized receptors, or in the replenishment of new receptors at the cell surface. It can be correlated, however, with the half-life of internalization of the bound agonist, which is approximately 60 min in Leydig tumor cells and about 100 min in transfected 293 cells. To determine whether the rate of internalization of the bound agonist affects down-regulation, we compared these two parameters in 293 cells expressing four rLHR mutants that enhance internalization and three mutants that impair internalization. We show that all four mutations of the rLHR that enhanced internalization enhanced down-regulation, while only one of the three mutations that impaired internalization impaired down-regulation. In addition, cotransfections of 293 cells with the rLHR-wt and three constructs that enhanced internalization (G protein-coupled receptor kinase 2, beta-arrestin, and arrestin-3) increased down-regulation, while a related construct (visual arrestin) that had no effect on internalization also had no effect on down-regulation. We conclude that the rate of internalization of the agonist-LHR complex is the main determinant of the extent of down-regulation of the LHR.
在用大鼠促黄体生成素/绒毛膜促性腺激素受体(rLHR)转染的人肾293细胞中,激动剂诱导的rLHR下调程度远低于两种内源性表达啮齿动物LHR的睾丸间质细胞瘤细胞系(MA - 10和R2C)。这种差异不能归因于内化受体的再循环差异,也不能归因于细胞表面新受体的补充差异。然而,它可能与结合激动剂的内化半衰期相关,在睾丸间质细胞瘤细胞中约为60分钟,在转染的293细胞中约为100分钟。为了确定结合激动剂的内化速率是否影响下调,我们在表达四种增强内化的rLHR突变体和三种损害内化的突变体的293细胞中比较了这两个参数。我们发现,增强内化的rLHR的所有四种突变都增强了下调,而损害内化的三种突变中只有一种损害了下调。此外,将293细胞与rLHR - wt和三种增强内化的构建体(G蛋白偶联受体激酶2、β - 抑制蛋白和抑制蛋白 - 3)共转染会增加下调,而对内化无影响的相关构建体(视觉抑制蛋白)对下调也无影响。我们得出结论,激动剂 - LHR复合物的内化速率是LHR下调程度的主要决定因素。